No abstract available
MeSH terms
-
Anticoagulants / therapeutic use*
-
COVID-19 Vaccines / adverse effects*
-
ChAdOx1 nCoV-19
-
Combined Modality Therapy
-
Female
-
Fibrin Fibrinogen Degradation Products / analysis
-
Glucocorticoids / therapeutic use
-
Humans
-
Immunoglobulins, Intravenous / therapeutic use
-
Methylprednisolone / therapeutic use
-
Middle Aged
-
Plasma Exchange*
-
Platelet Count
-
Prednisone / therapeutic use
-
Purpura, Thrombocytopenic, Idiopathic / etiology
-
Purpura, Thrombocytopenic, Idiopathic / therapy*
-
Thrombosis / etiology
-
Thrombosis / therapy*
Substances
-
Anticoagulants
-
COVID-19 Vaccines
-
Fibrin Fibrinogen Degradation Products
-
Glucocorticoids
-
Immunoglobulins, Intravenous
-
fibrin fragment D
-
ChAdOx1 nCoV-19
-
Prednisone
-
Methylprednisolone